In this work, we propose a novel immunoassay platform for the detection of human Thyroglobulin (Tg) to be integrated with fine-needle aspiration biopsy for early identification of lymph node metastases in thyroid cancer patients. The sensing platform detects Tg (a well-known biomarker for the classification of metastatic lymph nodes related to thyroid cancer) by a sandwich immunoassay involving a self-assembled surface-enhanced Raman scattering (SERS) substrate assisted and empowered by functionalized gold nanoparticles enabling additional Raman signal amplification and improved molecular specificity. The sandwich assay platform was preliminary validated in a planar configuration and a detection limit as low as 7 pg/mL was successfully achieved. The sandwich assay was successfully demonstrated on washout fluids of fine needle aspiration biopsies from cancer patients and confirmed the high specificity of the proposed methodology when complex biological matrices are considered. Finally, optical fiber SERS optrodes were fabricated and successfully used to detect Tg concentration by applying the same bio-recognition strategy. This opens the possibility of transferring the Tg detection approach to the optical fiber tip to develop point-of-care platforms that can be directly integrated into fine needle aspiration biopsies.
Access to the requested content is limited to institutions that have purchased or subscribe to SPIE eBooks.
You are receiving this notice because your organization may not have SPIE eBooks access.*
*Shibboleth/Open Athens users─please
sign in
to access your institution's subscriptions.
To obtain this item, you may purchase the complete book in print or electronic format on
SPIE.org.
INSTITUTIONAL Select your institution to access the SPIE Digital Library.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.